![Yusuke Nakamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 6 M $ au 30/06/2026
Yusuke Nakamura is currently the President of the National Institutes of Biomedical Innovation, Health & Nutrition.
He previously worked as a Director at OncoTherapy Science, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
20,53 % | 31/10/2025 | 1 000 000 ( 20,53 % ) | 4 M $ | 30/06/2026 |
| 30/09/2025 | 12 511 000 ( 3,14 % ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Natl Institutes of Biomedical Innovation, Health & Nutrition
 Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | President | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
OncoTherapy Science, Inc.
 OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
Natl Institutes of Biomedical Innovation, Health & Nutrition
Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | Government |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
